Sunmax Biotechnology (Taiwan) Today
| 4728 Stock | TWD 275.50 2.50 0.90% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sunmax Biotechnology is selling for under 275.50 as of the 22nd of November 2024; that is 0.9 percent decrease since the beginning of the trading day. The stock's lowest day price was 275.5. Sunmax Biotechnology has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sunmax Biotechnology Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Moving against Sunmax Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sunmax Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sunmax Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sunmax Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Biotech (View all Themes) |
| Business Concentration | Biotech, Biotechnology, Healthcare (View all Sectors) |
Sunmax Biotechnology Co (4728) is traded on Taiwan OTC Exchange in Taiwan and employs 22 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sunmax Biotechnology's market, we take the total number of its shares issued and multiply it by Sunmax Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sunmax Biotechnology operates under Healthcare sector and is part of Biotechnology industry. The entity has 54.46 M outstanding shares.
Sunmax Biotechnology generates positive cash flow from operations, but has no cash available
Check Sunmax Biotechnology Probability Of Bankruptcy
Ownership AllocationSunmax Biotechnology shows a total of 54.46 Million outstanding shares. Sunmax Biotechnology maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sunmax Ownership Details
Sunmax Biotechnology Risk Profiles
Although Sunmax Biotechnology's alpha and beta are two of the key measurements used to evaluate Sunmax Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.12 | |||
| Semi Deviation | 1.3 | |||
| Standard Deviation | 1.47 | |||
| Variance | 2.15 |
Sunmax Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sunmax Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Additional Tools for Sunmax Stock Analysis
When running Sunmax Biotechnology's price analysis, check to measure Sunmax Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunmax Biotechnology is operating at the current time. Most of Sunmax Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sunmax Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunmax Biotechnology's price. Additionally, you may evaluate how the addition of Sunmax Biotechnology to your portfolios can decrease your overall portfolio volatility.